Copper-induced tumor cell death mechanisms and antitumor theragnostic applications of copper complexes
Y Jiang, Z Huo, X Qi, T Zuo, Z Wu - Nanomedicine, 2022 - Taylor & Francis
Recent studies found that unbalanced copper homeostasis affect tumor growth, causing
irreversible damage. Copper can induce multiple forms of cell death, including apoptosis …
irreversible damage. Copper can induce multiple forms of cell death, including apoptosis …
Leveraging disulfiram to treat cancer: Mechanisms of action, delivery strategies, and treatment regimens
Y Lu, Q Pan, W Gao, Y Pu, K Luo, B He, Z Gu - Biomaterials, 2022 - Elsevier
Disulfiram (DSF) has been used as an alcoholism drug for 70 years. Recently, it has
attracted increasing attention owing to the distinguished anticancer activity, which can be …
attracted increasing attention owing to the distinguished anticancer activity, which can be …
New anti-cancer explorations based on metal ions
H Hu, Q Xu, Z Mo, X Hu, Q He, Z Zhang… - Journal of …, 2022 - Springer
Due to the urgent demand for more anti-cancer methods, the new applications of metal ions
in cancer have attracted increasing attention. Especially the three kinds of the new mode of …
in cancer have attracted increasing attention. Especially the three kinds of the new mode of …
Affimer Tagged Cubosomes: Targeting of Carcinoembryonic Antigen Expressing Colorectal Cancer Cells Using In Vitro and In Vivo Models
Nanomedicines, while having been approved for cancer therapy, present many challenges
such as low stability, rapid clearance, and nonspecificity leading to off-target toxicity …
such as low stability, rapid clearance, and nonspecificity leading to off-target toxicity …
Radiolabeled nanomaterials for biomedical applications: radiopharmacy in the era of nanotechnology
Background Recent advances in nanotechnology have offered new hope for cancer
detection, prevention, and treatment. Nanomedicine, a term for the application of …
detection, prevention, and treatment. Nanomedicine, a term for the application of …
Copper complexes as anticancer agents targeting topoisomerases I and II
C Molinaro, A Martoriati, L Pelinski, K Cailliau - Cancers, 2020 - mdpi.com
Simple Summary Organometallics, such as copper compounds, are cancer
chemotherapeutics used alone or in combination with other drugs. One small group of …
chemotherapeutics used alone or in combination with other drugs. One small group of …
What are the prospects for using complexes of copper (II) and zinc (II) to suppress the vital activity of Mycolicibacterium smegmatis?
IA Lutsenko, DE Baravikov, KA Koshenskova… - RSC …, 2022 - pubs.rsc.org
New complexes of zinc (II) and copper (II) with 2-furoic acid (Hfur), acetic acids and N-donor
ligands with the compositions [Zn2 (fur) 4] n (1),[Zn2 (fur) 4 (NH2py) 2](2, NH2py= 3 …
ligands with the compositions [Zn2 (fur) 4] n (1),[Zn2 (fur) 4 (NH2py) 2](2, NH2py= 3 …
[HTML][HTML] Copper (II) phenanthroline-based complexes as potential anticancer drugs: a walkthrough on the mechanisms of action
Copper is an endogenous metal ion that has been studied to prepare a new antitumoral
agent with less side-effects. Copper is involved as a cofactor in several enzymes, in ROS …
agent with less side-effects. Copper is involved as a cofactor in several enzymes, in ROS …
Multifaceted roles of copper ions in anticancer nanomedicine
S Yang, Y Song, Y Hu, HJ Chen… - Advanced Healthcare …, 2023 - Wiley Online Library
The significantly increased copper level in tumor tissues and serum indicates the close
association of copper ions with tumor development, making copper ions attractive targets in …
association of copper ions with tumor development, making copper ions attractive targets in …
[HTML][HTML] Theoretical investigation and antineoplastic potential of Zn (II) and Pd (II) complexes of 6-methylpyridine-2-carbaldehyde-N (4)-ethylthiosemicarbazone
Abstract Density Functional Theoretical (DFT) and molecular docking studies have been
used to elucidate the antineoplastic potential of the ligand 6-Methylpyridine-2-carbaldehyde …
used to elucidate the antineoplastic potential of the ligand 6-Methylpyridine-2-carbaldehyde …